https://www.nature.com/articles/s41598-021-95565-8
"COVID-19 can involve persistence, sequelae, and other medical complications
that last weeks to months after initial recovery. This systematic review and
meta-analysis aims to identify studies assessing the long-term effects of
COVID-19. LitCOVID and Embase were searched to identify articles with original
data published before the 1st of January 2021, with a minimum of 100 patients.
For effects reported in two or more studies, meta-analyses using a
random-effects model were performed using the MetaXL software to estimate the
pooled prevalence with 95% CI. PRISMA guidelines were followed. A total of
18,251 publications were identified, of which 15 met the inclusion criteria.
The prevalence of 55 long-term effects was estimated, 21 meta-analyses were
performed, and 47,910 patients were included (age 17–87 years). The included
studies defined long-COVID as ranging from 14 to 110 days post-viral infection.
It was estimated that 80% of the infected patients with SARS-CoV-2 developed
one or more long-term symptoms. The five most common symptoms were fatigue
(58%), headache (44%), attention disorder (27%), hair loss (25%), and dyspnea
(24%). Multi-disciplinary teams are crucial to developing preventive measures,
rehabilitation techniques, and clinical management strategies with
whole-patient perspectives designed to address long COVID-19 care."
Via Laurent Espitallier and Christoph S.
Cheers,
*** Xanni ***
--
mailto:xanni@xanadu.net Andrew Pam
http://xanadu.com.au/ Chief Scientist, Xanadu
https://glasswings.com.au/ Partner, Glass Wings
https://sericyb.com.au/ Manager, Serious Cybernetics
